A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults

Biomarkers

Volumn 15, Issue 6, 2010, Pages 553-562

  Turner, Paul C ^a   White, Kay L M ^a   Burley, Victoria J ^b   Hopton, Richard P ^a   Rajendram, Anita ^b   Fisher, Julie ^a   Cade, Janet E ^b   Wild, Christopher P ^a,c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Biomarker; Deoxynivalenol; Diet; UK; Urine; Validation

Indexed keywords

CREATININE; VOMITOXIN;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CEREAL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FOOD CONTAMINATION; FOOD INTAKE; HUMAN; MALE; SEX DIFFERENCE; UNITED KINGDOM; URINALYSIS; URINE LEVEL; WHEAT;

ADULT; BIOLOGICAL MARKERS; BREAD; CEREALS; CREATININE; DIET; DIET RECORDS; FEMALE; FOOD CONTAMINATION; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; TRICHOTHECENES; YOUNG ADULT;

TRITICUM AESTIVUM;

EID: 77955862759     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2010.495787     Document Type: Article

References (49)

1. Amuzie CJ, Pestka JJ. (2010). Suppression of insulin like growth factor acid labile subunit (IGFALS) expression-a novel mechanism for deoxynivalenol induced growth retardation. Toxicol Sci 113:412-421
2. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. (2005). Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 113:192-200.
3. Bhat RV Beedu SR, Ramakrishna Y, Munshi KL. (1989). Outbreak of trichothecenes mycotoxicosis associated with consumption of mould-damaged wheat production in Kashmir Valley, India. Lancet 1:35-37
4. Canady R, Coker R, Egan S, Krska R, Kuiper-Goodman T, Olsen M, Pestka J, Resnik S, Schlatter J. (2001). Deoxynivalenol. In: Safety Evaluation of Certain Mycotoxins in Food. Geneva: World Health Organization.
5. CAST. (2003). Potential economic costs of mycotoxins in the United States. In: Mycotoxins: Risks in Plant, Animal, and Human Systems. Task Force Report no. 139. Ames, IA: Council for Agricultural Science and Technology. p.136-142
6. Department of Health. (1991). Dietary reference values for food energy and nutrients for the United Kingdom. Report of the panel on dietary reference values of the committee on medical aspects of food policy. London: Department of Health.
7. Egner PA, Wang JB, Zhu YR, Zhang BC, Wu Y, Zhang QN, Qian GS, Kuang SY, Gange SJ, Jacobson LP, Helzlsouer KJ, Bailey GS, Groopman JD, Kensler TW. (2001). Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci USA 98:14601-14606
8. EU. (2006). Laying down the methods of sampling and analysis for the official control of the levels of mycotoxins in foodstuffs. Commission regulation (EC) no. 401/2006. Available at: http://www.health.gov.mt/fsc/fsc-EU. eg-files/RegEC401-2006e.pdf (last accessed 18 May 2010)
9. Gilbert J, Brereton P, MacDonald S. (2001). Assessment of dietary exposure to ochratoxin A in the UK using a duplicate diet approach and analysis of urine and plasma samples. Food Add Contam 18:1088-1093
10. Gong Y, Torres-Sanchez L, Lopez-Carrillo L, Peng JH, Sutcliffe AE, White KLM, Turner PC, Humpf H, Wild CP. (2008). Detection of fumonisin B1 in Mexican urine samples using liquid chromatogra-phy-mass spectrometry-a possible biomarker of dietary fumonisin exposure. Cancer Epidemiol Biomarkers Prev 17:688-694
11. Gong YY, Cardwell K, Hounsa A, Egal S, Turner PC, Hall AJ, Wild CP. (2002). Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo, West Africa: cross sectional study. BMJ 325:20-21
12. Goyarts T, Danicke S. (2006). Bioavailability of the Fusarium toxin deoxynivalenol (DON) from naturally contaminated wheat for the pig. Toxicol Lett 163:171-182
13. Gray JS, Pestka JJ. (2007). Transcriptional regulation of deoxynivale-nol-induced IL-8 expression in human monocytes. Toxicol Sci 99:502-511
14. Groopman JD, Jackson PE, Turner PC, Wild CP, Kensler TW. (2002). Validation of exposure and risk biomarkers: aflatoxin as a case study. In: Wilson SH, Suk WA, eds. Biomarkers of Environmentally Associated Disease. Boca Raton, FL: CRC Press. p. 307-318
15. Groopman JD, Wild CP, Hasler J, Junshi C, Wogan GN, Kensler TW. (1993). Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans. Environ Health Perspect 99:107-113
16. Holland B, Welch AA, Unwin ID, Buss DH, Paul AA, Southgate DAT. (1992). McCanceand Widdowsons The Composition of Foods, 5th edn. London: The Royal Society of Chemistry and the Ministry of Agriculture Fisheries and Food.
17. Hopton RP, Turner E, Burley VJ, Turner PC, Fisher J. (2010). Urine metabolite analysis as a function of deoxynivalenol exposure: an NMR-based metabolomics investigation. Food Add Contam 27:255-261
18. International Agency for Research on cancer (IARC). (2002). Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. Report no. 82. Lyon: World Health Organization, IARC. p. 1-556.
19. Jiang Y, Jolly PE, Ellis WO, Wang JS, Phillips TD, Williams JH. (2005). Aflatoxin B1 albumin adduct levels and cellular immune status in Ghanaians. Int Immunol 17:807-814
20. Joint Expert Committee on Food Additives. (2001). Deoxynivalenol. Available at: http://www.inchem.org/documents/jecfa/jec-mono/v47je05.htm (last accessed 15 June 2007).
21. Kensler TW, He X, Otieno M, Egner PA, Jacobson LP, Chen B, Wang J, Zhu W, Zhang B, Wang J, Wu Y, Zhang Q, Qian G, Kuang S, Fang X, Li Y, Yu L, Prochaska HJ, Davidson NE, Gordon GB, Gorman MB, Zarba A, Enger C, Munoz A, Helzlsouer KJ, Groopman JD. (1998). Oltipraz chemoprevention trial in Qidong, Peoples Republic of China: modulation of serum aflatoxins-albu-min adduct biomarkers. Cancer Epidemiol Biomarkers Prev 7:127-134
22. Luo X. (1994). Food poisoning caused by Fusarium toxins. In: Proceedings of the Second Asian Conference on Food Safety. p. 129-136
23. Meky FA, Hardie LJ, Evans SW, Wild CP. (2001). Deoxynivalenol-induced immunomodulation of human lymphocyte proliferation and cytokine production. Food Chem Toxicol 39:827-836
24. Meky FA, Turner PC, Ashcroft AE, Miller JD, Qiao YL, Roth MJ, Wild CP. (2003). Development of a urinary biomarker of human exposure to deoxynivalenol. Food Chem Toxicol 41:265-273
25. Miller JD. (1995). Fungi and mycotoxins in grain: implications for stored product research. J Stored Prod Res 31:1-16.
26. Nikiema PN, Worrilow L, Traore AS, Wild CP, Turner PC. (2008). Fumonisin exposure and the Shinganine/Sphingosine ratio in urine, serum and buccal cells in adults from Burkina Faso, West Africa. World Mycotoxin J 1:483-491
27. Pestka JJ, Zhou HR, Moon Y, Chung YJ. (2004). Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: unraveling a paradox. Toxicol Lett 153:61-73.
28. Pestka, JJ, Smolinski AT. (2005). Deoxynivalenol: toxicology and potential effects on humans. J Toxicol Environ Health B Crit Rev 8:39-69.
29. Prelusky DB, Hartin KE, Trenholm HL, Miller JD. (1998). Pharmacokinetic fate of 14C-labeled deoxynivalenol in swine. Fundam Appl Toxicol 10:276-286
30. Prelusky DB. (1997). Effect of intraperitoneal infusion of deoxynivale-nol on feed consumption and weight gain in the pig. Nat Toxins 5:121-125
31. Rotter BA, Prelusky DB, Pestka JJ. (1996). Toxicology of deoxynivalenol (vomitoxin). J Toxicol Environ Health 48:1-34.
32. SCF (2002). Opinion of the Scientific Committee on Food on Fusarium toxins. Part 6: Group evaluation of T-2 toxin, HT-2 toxin, niva-lenol and deoxynivalenol: 2002SCF/CS/CNTM/MYC/27 Final. Available at: http://ec.europa.eu/ geninfo/query/resultaction. jsp?userinput=SCF%202002%20deoxynivalenol (accessed 18th June 2010).
33. SCOOP. (2003). Collection of occurrence data of Fusarium toxins in food and assessment of dietary intake by the population of EU member states. scoop Task 3.2.10 Final report. Available at: (accessed 18th June 2010).
34. Shephard GS, Van der Westhuizen L, Sewram V. (2007). Biomarkers of exposure to fumonisin mycotoxins: a review. Food Add Contam 24:1196-1201
35. Sugiyama KI, Muroi M, Tanamoto KI, Nishijima, M, Sugita-Konishi Y. (2010). Deoxynivalenol and nivalenol inhibit lipopolysaccharide-induced nitric oxide production by mouse macrophage cells. Toxicol Lett 192:150-154
36. Turner PC, Burley VJ, Rothwell JA, White KLM, Cade JE, Wild CP. (2008b). Deoxynivalenol: rationale for development and application of a urinary biomarker. Food Add Contam 25:864-871
37. Turner PC, Burley VJ, Rothwell JA, White KLM, Cade JE, Wild CP. (2008a). Dietary wheat reduction decreases the level of urinary deoxynivalenol in UK adults. J Exposure Sci Env Epidemiol 18:392-399
38. Turner PC, Collinson AC, Cheung YB, Gong Y, Hall AJ, Prentice AM, Wild CP. (2007). Aflatoxin exposure in utero causes growth faltering in Gambian infants. Int J Epidemiol 36:1119-1125
39. Turner PC, Hopton RP, Lecluse Y, White KLM, Fisher J, Lebailly P. (2010). Determinants of urinary deoxynivalenol and de-epoxy deoxynivalenol in male farmers from Normandy, France. J Agri Food Chem 58:5206-5212
40. Turner PC, Moore SE, Hall AJ, Prentice AM, Wild CP. (2003). Modification of immune function through exposure to dietary aflatoxin in Gambian children. Environ Health Persp 111:217-220
41. Turner PC, Nikiema P, Wild CP. (1999). Fumonisin contamination of food: progress in development of biomarkers to better assess human health. Mut Res 443:81-93.
42. Turner PC, Rothwell JA, White KLM, Cade JE, Wild CP. (2008c). Urinary deoxynivalenol is correlated with cereal intake in individuals from the United Kingdom Environ Health Persp 116:21-25
43. Turner PC, Sylla A, Gong YY, Diallo MS, Sutcliffe AE, Hall AJ, Wild CP. (2005). Reduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in West Africa: a community-based intervention study. Lancet 365:1950-1956
44. Turner PC, Taylor F, White KLM, Cade JE, Wild CP. (2009). A comparison of 24 hour urinary deoxynivalenol with recent versus usual cereal consumption for UK adults. Br J Nutr 102:1276-1279
45. Van De Walle J, Romier B, Larondelle Y, Schneider YJ. (2008). Influence of deoxynivalenol on NF-kappaB activation and IL-8 secretion in human intestinal Caco2 cells. Toxicol Lett 177:205-214
46. Varley H. (1967). Practical Clinical Biochemistry. London and New York: William Weimann Medical Books and Interscience Books, Inc.
47. Voss KA. (2009) A new perspective on deoxynivalenol and growth suppression. Toxicol Sci 113:281-283
48. Wache YJ, Hbabi-Haddioui L, Guzylack-Pirou, Belkhelfa H, Roques C, Oswald IP. (2009). The mycotoxin deoxynivalenol inhibits the cell surface expression of activation markers in human macrophages. Toxicology 262:239-244
49. Wang P, Afriyie-Gyawu E, Tang Y, Johnson NM, Xu L, Tang L, Huebner HJ, Ankrah NA, Ofori-Adjei D, Ellis W, Jolly PE, Williams JH, Wang JS, Phillips TD. (2008). NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis: II. Reduction in in biomarkers of aflatoxins exposure in blood and urine. Food Add Contam Part A Chem Anal Control Expo Risk Assess 25:622-634